1. Current genetics of essential hypertension

   • Tomohiro Katsuya
   • Toshio Ogihara

   Invited Commentary Pages: 1 - 2

2. Editorial

   • P. A. van Zwieten
   • B. N. C. Prichard
   • N. K. Hollenberg

   EditorialNotes Pages: S1 - S1

3. Web alert

   News Pages: 3 - 5

4. Sympathetic overactivity in hypertension: A risk factor for cardiovascular disease

   • Paolo Palatini

   OriginalPaper Pages: S3 - S9

5. Literature alert

   Abstract Pages: 6 - 8

6. Systolic hypertension and cardiovascular risk reduction: A clinical review

   • William C. Cushman

   ReviewPaper Pages: S11 - S15

7. The use of designer rats in the genetic dissection of hypertension

   • Anne E. Kwitek-Black
   • Howard J. Jacob

   OriginalPaper Pages: 12 - 18

8. Differentiation in the Angiotensin II Receptor 1 blocker class on autonomic function

   • Henry Krum

   OriginalPaper Pages: S17 - S23

9. Racial differences and the genetics of hypertension

   • Richard S. Cooper
   • Xiaofeng Zhu

   OriginalPaper Pages: 19 - 24

10. Potential of the angiotensin II receptor 1 blocker eprosartan in the management of patients with hypertension or heart failure

    • Norman K. Hollenberg

    OriginalPaper Pages: S25 - S28

11. Psychologic factors as precursors to hypertension

    • Jerome H. Markovitz
    • Bruce S. Jonas
    • Karina Davidson

    OriginalPaper Pages: 25 - 32

12. Telomeres: The time factor in essential hypertension

    • Abraham Aviv
    • Walter Zahorodny

    OriginalPaper Pages: 33 - 35

13. The future of gene therapy for stroke

    • Carol A. Gunnett
    • Donald D. Heistad

    OriginalPaper Pages: 36 - 40

14. Mouse models of blood pressure regulation and hypertension

    • Fumihiro Sugiyama
    • Kenichi Yagami
    • Beverly Paigen

    OriginalPaper Pages: 41 - 48

15. Antihypertensive drug therapy and risk of developing diabetes mellitus

    • Alan B. Weder

    Clinical Trials Report Pages: 49 - 49

16. Antihypertensive drugs and events: Answers from INSIGHT and NORDIL

    • Ernesto L. Schiffrin

    Clinical Trials Report Pages: 51 - 51

17. NORDIL study

    • Ernesto L. Schiffrin

    Clinical Trials Report Pages: 51 - 52

18. Antioxidants and endothelial dysfunction in Hyperlipidemia

    • Ascan Warnholtz
    • Hanke Mollnau
    • Thomas Münzel

    OriginalPaper Pages: 53 - 60

19. Angiotensin, inflammation, hypertension, and cardiovascular disease

    • Friedrich C. Luft

    OriginalPaper Pages: 61 - 67

20. Knockout of renin-angiotensin system genes: Effects on vascular development

    • Danielle Methot
    • Timothy L. Reudelhuber

    OriginalPaper Pages: 68 - 73

21. Effect of hypertension on viscoelasticity of large arteries in humans

    • Alain Simon
    • Jaime Levenson

    OriginalPaper Pages: 74 - 78

22. Effects of blood pressure and glucose on endothelial function

    • Francesco Cosentino
    • Thomas F. Lüscher

    OriginalPaper Pages: 79 - 88